Navigation Links
Pivotal Registration Trial of OPAXIO Maintenance Therapy in First-Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients, Cell Therapeutics and the Gynecologic Oncology Group Discuss Potential for Early Interim Analysis
Date:9/21/2009

ation pathway for OPAXIO."

"We believe focusing on ovarian maintenance, and radiosensitization, not only address areas of unmet medical need, but are in the best long term strategic interest of CTI. With the FDA review of the NDA for pixantrone in relapsed/refractory non-Hodgkin's lymphoma well underway and the phase III Ovarian trial of OPAXIO progressing nicely we are pleased with the advancement and future potential of these novel treatments," said James A. Bianco, M.D., CEO of CTI.

CTI has an existing license and co-development agreement with Novartis for OPAXIO(TM) (paclitaxel poliglumex, CT-2103), which also provides Novartis with an option to enter into an exclusive worldwide license to develop and commercialize pixantrone based upon agreed terms.

About OPAXIO

OPAXIO(TM) (paclitaxel poliglumex, CT-2103), which was formerly known as XYOTAX(TM), is an investigational, biologically enhanced, chemotherapeutic that links paclitaxel, the active ingredient in Taxol(R), to a biodegradable polyglutamate polymer, which results in a new chemical entity. When bound to the polymer, the chemotherapy is rendered inactive, potentially sparing normal tissue's exposure to high levels of unbound, active chemotherapy and its associated toxicities. Blood vessels in tumor tissue, unlike blood vessels in normal tissue, are porous to molecules like polyglutamate. Based on preclinical studies, it appears that OPAXIO is preferentially distributed to tumors due to their leaky blood vessels and trapped in the tumor bed allowing significantly more of the dose of chemotherapy to localize in the tumor than with standard paclitaxel. Once inside the tumor cell, enzymes metabolize the protein polymer, releasing the paclitaxel chemotherapy.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncol
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
5. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
6. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
7. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
8. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
9. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
10. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
11. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... April 27, 2015 Research ... addition of the "Endoscopy Global Market - ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,The ... $43 billion by 2019 growing at around 7.0% ... for the market growth are aging population, increase ...
(Date:4/27/2015)... 27, 2015 Vermillion, Inc. (VRML), ... disease, announced today it will report first ... close on Monday, May 11, 2015, followed ... at 4:30pm Eastern.Conference Call & Webcast: Monday, ... Domestic: , 888-556-4997International: , 719-457-2628Conference ID: , ...
(Date:4/27/2015)... 2015  Agena Bioscience today announced Bioyong Technology as the ... in China . "The Chinese ... hotbed for practical, meaningful innovations that are improving human health ... rest of the world. We are proud to support the ... ," said Peter Dansky , Agena Bioscience,s CEO. ...
Breaking Medicine Technology:Endoscopy Global Market - Forecast to 2020: Market is expected to reach approximately $43 billion with Johnson and Johnson, Olympus and Covidien Dominating 2Endoscopy Global Market - Forecast to 2020: Market is expected to reach approximately $43 billion with Johnson and Johnson, Olympus and Covidien Dominating 3Agena Bioscience Names Bioyong Technology as Fifth Certified Service Provider in China 2
...  BioInformatics, LLC announces the pending release of three Q4 ... & Brand Assessment (#10-006) Exploring Structural Biology:  Tools ... Structure (#10-004) Genomic Technologies:  Market Insights for Life ... who provide product and services to these three rapidly ...
... Oct. 14 Octapharma USA ... Grants Program , which supports clinical or pre-clinical research ... therapy, intensive care and emergency medicine. The application deadline ... , one of the largest human protein products manufacturers ...
Cached Medicine Technology:BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure 2BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure 3BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure 4Octapharma Accepting Applications for Research Grants Focused on Human Protein Therapies 2
(Date:4/27/2015)... As ISO 27001 has quickly become the de ... sizes and in all industries, Pivot Point Security has ... 27001 certification. The information security audit firm has worked ... 27001 certification. Pivot Point's commitment to ISO 27001 is ... Lead Implementers and Auditors the company employs (now ten ...
(Date:4/27/2015)... Data Integrity Problems on the Rise: , ... Partners/Suppliers, **FDAnews Webinar**, May 19, 2015 — 1:30 p.m. ... integrity issues have become a common and ever increasing ... issues within manufacturing operations or partner networks can be ... remediating them can be even more difficult. , ...
(Date:4/27/2015)... 27, 2015 Cannabix Technologies Inc. (CSE: ... Mr. Rocco Iannapollo has become an Advisor to Cannabix ... law enforcement and workplace testing. Mr. Iannapollo is an ... years of experience in the oil and gas industry, ... with supplier, employer, and DOT compliance policies and strategies. ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 The ... at a lower CAGR in developed countries; however, ... emerging countries such as China, India and Brazil ... coagulation analyzers market is driven by factors such ... diagnostics laboratories, development of high-throughput hemostasis analyzers, developments ...
(Date:4/27/2015)... April 27, 2015 The Global Pharmaceutical ... at a CAGR of 5.9% during the period 2015 ... in the materials healthcare packaging market, mainly due to ... Pharmaceutical Packaging market is extremely fragmented with the ... major portion of the market with the rest being ...
Breaking Medicine News(10 mins):Health News:Six Additional New ISO 27001 Lead Implementers Certified for Pivot Point Security 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 3Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 4Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 2Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 3Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 4Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 2Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 3Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 2Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 3Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 4
... (May 8, 2011) Research being presented at ... diet affects gastrointestinal illnesses, such as gallstones and ... their digestive problems are caused by lactose intolerance ... DDW is the largest international gathering of physicians ...
... drug often prescribed for women with Crohn,s disease, actively ... and remains in a newborn,s bloodstream for at least ... Francisco have found. The new study has ... because ADA is known to decrease the immune system,s ...
... FRIDAY, May 6 (HealthDay News) -- Mutations in a single ... of the human cerebral cortex, the part of the brain ... language, memory, attention and consciousness. That,s the finding of ... three families -- one Turkish, two Pakistani -- with children ...
... -- Fathers have a major influence on how often their ... research shows. The study included 312 families in Houston ... about family meals and the amount of time the children ... families were aged 9 to 11 and 13 to 15. ...
... Reporter , THURSDAY, May 5 (HealthDay News) -- ... appendicitis, surgery remains the more effective treatment, French ... with antibiotics alone, but complicated appendicitis, where the ... difficult to discern between the two, the researchers ...
... Dr. Rino Rappuoli has been chosen to receive the 2011 ... by the European Society of Clinical Microbiology and Infectious Diseases ... his outstanding contributions in the field of vaccines and vaccinology. ... researcher at the 21st ECCMID / 27th ICC meeting in ...
Cached Medicine News:Health News:Dietary research offers new explanations and treatments approaches for gastrointestinal disorders 2Health News:Dads Who Eat Out Have Kids Who Eat Out, Study Finds 2Health News:Surgery May Beat Antibiotics for Appendicitis, Study Finds 2Health News:Surgery May Beat Antibiotics for Appendicitis, Study Finds 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: